Dr Rachel E. Speer brings to ECIR a range of scientific and medical communications experience, spanning continuing medical/pharmacy education and continuing education, medical affairs, promotional medical education, sales training, and scientific marketing. Her therapeutic area expertise includes multiple sclerosis, migraine, Parkinson disease, Huntington disease, tardive dyskinesia, Alzheimer disease, amyotrophic lateral sclerosis, asthma, chronic obstructive pulmonary disease, nasal polyps, and other areas within neurology, cardiometabolic disorders, and women’s health.
Dr Speer joined ECIR in 2021 with 8 years of professional experience in scientific/medical communications and education. She completed her doctoral training in neuroscience at the Weill Cornell Graduate School of Medical Sciences, where she investigated hypoxia signaling in models of ischemic stroke. Prior to graduate school, she completed a 2-year postbaccalaureate research fellowship at the National Institutes of Health and received a bachelor degree from Amherst College, with majors in biology and history.
Over the course of her career, Dr Speer has gained experience leading commercial and medical affairs initiatives across all stages of a product life cycle, including strategic advisory boards, scientific platform development, key opinion leader engagement, disease state and branded asset development (eg, slide deck presentations, patient cases, videos), speakers’ bureau content development and training, medical science liaison training and external presentations, congress support, competitive intelligence analysis, and other customized deliverables and consultative services that meet clients’ diverse needs. She is passionate about collaboration and lifelong learning as key means to executing high-impact initiatives that will improve patient outcomes.